872728-84-2

Basic information

• Product Name: ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate
• Synonyms: ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate;.beta.-Alanine, N-[[2-[[[4-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester;Ethyl 3-(1-methyl-2-(((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)amino)-methyl)-N-(pyridin;Ethyl 3-(1-methyl-2-(((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl);-N-(pyridin-2-yl);Ethyl 3-(1-methyl-2-(((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl)amino)-methyl)-N-(pyri
• CAS NO: 872728-84-2
• Molecular Formula: C₂₈H₂₇N₇O₅
• Molecular Weight: 543.57376
• Mol File: 872728-84-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate(872728-84-2)
• EPA Substance Registry System: ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate(872728-84-2)

Safety Data

• Hazardous Substances Data: 872728-84-2(Hazardous Substances Data)

Usage

General Description

Ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylamino)methyl)-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate is a complex chemical compound with a long, intricate name. It is an organic compound that consists of various functional groups, including ester, amide, imidazole, and oxadiazole. ethyl 3-(1-Methyl-2-((4-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenylaMino)Methyl)-N-(pyridin-2-yl)-1H-benzo[d]iMidazole-5-carboxaMido)propanoate may have potential applications in pharmaceuticals, agrochemicals, or materials science due to its structural complexity and potential biological activity. However, further research and analysis would be needed to fully understand its properties and potential uses.

InChI:InChI=1S/C28H27N7O5/c1-3-39-25(36)13-15-35(23-6-4-5-14-29-23)27(37)19-9-12-22-21(16-19)31-24(34(22)2)17-30-20-10-7-18(8-11-20)26-32-28(38)40-33-26/h4-12,14,16,30H,3,13,15,17H2,1-2H3,(H,32,33,38)

Upstream product

• 872728-82-0 2-[4-(1,2,4-oxadiazol-5-one-3-yl)-phenylamino]-acetic acid 
• 212322-56-0 ethyl 3-{[{2-amino-1-(methylamino)phen-4-yl}carbonyl](pyridyn-2-yl)amino}propanoate 

Downstream Products

• 429658-95-7 3-({2-[(4-carbamimidoylphenylamino)methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}pyridin-2-yl-amino)propionic acid ethyl ester 
• 872728-85-3 1-methyl-2-[N-(4-amidino-phenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid N-(2-pyridyl)-N-2-(ethoxycarbonylethyl)-amide p-toluenesulfonic acid salt 
• 211915-06-9 ethyl 3-(1-{2-[({4-[amino({[(hexyloxy)carbonyl]imino})methyl]phenyl}amino)methyl]-1-methyl-1H-1,3-benzodiazol-5-yl}-N-(pyridin-2-yl)formamido)propanoate 

Relevant articles and documents

METHOD FOR PRODUCING AN INTERMEDIATE PRODUCT OF DABIGATRAN ETEXILATE

The invention relates to a process for preparing the compound of formula 1 a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

IMPROVED PROCESS FOR THE PREPARATION OF THE SALTS OF 4-(BENZIMIDAZOLYLMETHYLAMINO)-BENZAMIDES

The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.